XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Net sales $ 14,293 $ 13,079 $ 38,819 $ 35,448
Cost of sales 10,291 9,268 28,357 26,058
Gross profit 4,002 3,811 10,462 9,390
Operating expenses:        
Selling expenses 17 24 79 146
General and administrative expenses 1,012 1,009 3,208 2,983
Research and development costs 760 713 2,353 2,109
Total operating expenses 1,789 1,746 5,640 5,238
Operating income 2,213 2,065 4,822 4,152
Interest expense 138 131 409 389
Unrealized gain (loss) on marketable equity investments (1,192) 242 (3,785) 3,407
Interest and other income 30 11 76 235
Gain on sale of investments 0 0 0 7
Income before income taxes 913 2,187 704 7,412
Income tax expense 258 570 164 1,840
Net income $ 655 $ 1,617 $ 540 $ 5,572
Basic net income per share:        
Net income $ 0.19 $ 0.46 $ 0.15 $ 1.56
Diluted net income per share:        
     Net income $ 0.19 $ 0.45 $ 0.15 $ 1.52
Weighted average common shares outstanding:        
Basic 3,451 3,548 3,531 3,580
Diluted 3,524 3,623 3,604 3,656
Common shares outstanding 3,451 3,545 3,451 3,545